Fischer Imaging receives SBIR grant for IBM initiative
The National Cancer Institute (NCI) has awarded Fischer Imaging Corp. a $1.2 million Small Business Innovation Research (SBIR) grant to fund a project with IBM Corp.

The companies will evaluate the technical performance and clinical efficacy of the IBM T221 flat-panel display as part of Fischer's SenoScan digital mammography review workstation.

FDA clearance will be required before the IBM 9-megapixel monitor can be made available to SenoScan customers.